Trial Profile
The Effects of the DPPIV Inhibitor Sitagliptin in Cystic Fibrosis-related Diabetes
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 06 Dec 2011 Planned End Date changed from 1 Jul 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 15 Dec 2010 New trial record